(Q41543803)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25590436%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25590436%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25590436%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Alessandro C Pasqualotto

series ordinal

3

object named as

Alessandro C Pasqualotto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25590436%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Franciane B da Rosa

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25590436%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

15 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25590436%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25590436%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25590436%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25590436%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

104-112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25590436%20AND%20SRC:MED&resulttype=core&format=json

Mortality and costs of acute renal failure associated with amphotericin B therapy

27 February 2020

cites work

1 reference

Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy

21 January 2018

1 reference

Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis

21 January 2018

1 reference

Amphotericin B nephrotoxicity

21 January 2018

1 reference

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

21 January 2018

1 reference

Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS.

21 January 2018

1 reference

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

21 January 2018

1 reference

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group

21 January 2018

1 reference

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

Defining acute renal failure: the RIFLE criteria

21 January 2018

1 reference

An assessment of the RIFLE criteria for acute renal failure in hospitalized patients

21 January 2018

1 reference

Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex

21 January 2018

1 reference

Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis

21 January 2018

1 reference

Validation of the Kidney Disease Improving Global Outcomes criteria for AKI and comparison of three criteria in hospitalized patients

21 January 2018

1 reference

Acute kidney injury: definition, epidemiology, and outcome

21 January 2018

1 reference

Amphotericin B lipid preparations: what are the differences?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/MYC.12283

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25590436%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference